| scholarly article | Q13442814 |
| P50 | author | Frances Quirk | Q57035328 |
| P2093 | author name string | Goldstein I | |
| Munarriz R | |||
| Jacobson J | |||
| Spark R | |||
| Traish A | |||
| Guay A | |||
| Talakoub L | |||
| P2860 | cites work | Sexual dysfunction in the United States: prevalence and predictors | Q33852255 |
| Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. | Q34590967 | ||
| Development of a sexual function questionnaire for clinical trials of female sexual dysfunction | Q34623296 | ||
| Screening for androgen deficiency in women: methodological and interpretive issues | Q34635776 | ||
| The Hormonal Activity of the Postmenopausal Ovary | Q39985067 | ||
| The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity | Q44089080 | ||
| Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood | Q50584310 | ||
| Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. | Q50943031 | ||
| Decreasing serum levels of sex hormone-binding globulin around the menopause and temporary relation to changing levels of ovarian steroids, as demonstrated in a longitudinal study | Q69963189 | ||
| Androgens and the menopause; a study of 40-60-year-old women | Q71931833 | ||
| A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density | Q72243376 | ||
| Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women | Q78196746 | ||
| P433 | issue | 2 | |
| P921 | main subject | sexual dysfunction | Q1137463 |
| P304 | page(s) | 112-120 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | International Journal of Impotence Research | Q15749221 |
| P1476 | title | Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49 years with no complaints of sexual dysfunction | |
| P478 | volume | 16 |
| Q36939272 | 'Off-label' drug use in sexual medicine treatment |
| Q35493460 | An evaluation of the effect of infertility on marital, sexual satisfaction indices and health-related quality of life in women |
| Q35143192 | Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors |
| Q46404291 | Effect of testosterone on the female anterior cruciate ligament |
| Q92304516 | Genetics of recurrent pregnancy loss among Iranian population |
| Q35508699 | Opioid analgesics suppress male gonadal function but opioid use in males and females does not correlate with symptoms of sexual dysfunction |
| Q44770307 | Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction. |
| Q36882931 | Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder. |
| Q36714838 | StuI polymorphism on the androgen receptor gene is associated with recurrent spontaneous abortion. |
| Q31164239 | Symptoms in peri- and postmenopausal women in relation to testosterone concentrations: data from The Women's Health in the Lund Area (WHILA) study |
| Q89414211 | Vitamin E as alternative local treatment in genitourinary syndrome of menopause: a randomized controlled trial |
Search more.